Purpose—Our goal is to provide an overview of the current evidence about components of
the evaluation and treatment of adults with acute ischemic stroke. The intended audience is …

This article reviews our current understanding of the cognitive processes involved in
diagnostic reasoning in clinical medicine. It describes and analyses the psychological …

Background and Purpose—Based on previous studies comparing different recombinant
tissue plasminogen activator (rt-PA) doses, we performed a clinical trial with 0.6 mg/kg …

1994 and December 2003 to identify studies relevant to the treatment of stroke and the
establishment of stroke systems. A range of search terms* identified 1000 articles of …

This chapter about treatment and prevention of stroke is part of the 7th ACCP Conference on
Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines. Grade 1 …

Nearly 15 years of increased stroke education and orga-nization has produced significant
strides in public awareness and development of stroke systems of care. Despite these …

dress these challenges. Additional expert panels will address the remaining components of
effective stroke systems. The ASA's Expert Panel comprises nationally recognized experts in …

Background and Purpose—Establishment of stroke centers, combined with accurate
paramedic diagnosis and rapid transport, is essential to deliver acute stroke therapy. We …

Background and Purpose—Despite Food and Drug Administration approval of tissue-type
plasminogen activator for stroke, obstacles in the US healthcare system prevent its …

Objectives: Telemedicine‐enabled acute stroke consultation (TeleStroke) may be useful to
determine eligibility for treatment with tissue plasminogen activator (tPA) and provide …